LOS ANGELES, Oct 6 (Reuters) - Gen-Probe Inc said on Tuesday it plans to acquire Prodesse Inc, a privately held provider of clinical tests for influenza and other infectious diseases, for around $60 ...
Hologic ($HOLX) will become a major player in molecular diagnostics focused on sexually transmitted diseases and boost its women's health expertise with the company's ...
Medical device maker Hologic Inc. has agreed to buy diagnostic test maker Gen-Probe Inc. for about $3.72 billion, expanding its portfolio in an area of medicine expected to see big growth. Gen-Probe ...
Firm has molecular tests for respiratory infectious diseases. Gen-Probe plans on acquiring Prodesse for approximately $60 million in cash. Achievement of certain financial and regulatory milestones in ...
NEW YORK (AP) -- Medical device maker Hologic Inc. came a step closer to completing its $3.76 billion acquisition of diagnostic test maker Gen-Probe Inc. after it passed a regulatory bar. The ...
The test has been approved to run on Gen-Probe's fully automated, high-throughput TIGRIS instrument system. Unlike available DNA-based tests, the APTIMA HPV assay detects messenger RNA over-expressed ...
ProFlu-ST is cleared for use until April 26, 2010. Gen-Probe has been granted an EUA (emergency use authorization) for the Prodesse ProFlu-ST™ to be used in CLIA high-complexity laboratories for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results